Press Releases :: Cellectar Biosciences, Inc. (CLRB)

Year

Release Type

Dec 14, 2017

Cellectar Files IND for Phase 1 Trial of CLR 131 in Pediatric Cancers

Dec 6, 2017

Cellectar Announces Expansion of Relapsed/Refractory Multiple Myeloma Cohort in Phase 2 Trial of CLR 131

Nov 20, 2017

Cellectar Biosciences to Present at the 10th Annual LD Micro Main Event

Nov 9, 2017

Cellectar Biosciences Reports Third Quarter 2017 Financial and Corporate Performance